Artykuły w czasopismach na temat „Thrombotic risk”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Thrombotic risk”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Cheng, Hai, Dian Zhou, Jiang Cao, Wei Chen, Kunming Qi, Kailin Xu i Jianlin Qiao. "A Study about the Relationship between Thrombotic Events and Peripheral Neutrophil-to-Lymphocyte Ratio in Patients with Newly Diagnosed Essential Thrombocythemia". Blood 132, Supplement 1 (29.11.2018): 5465. http://dx.doi.org/10.1182/blood-2018-99-112785.
Pełny tekst źródłaMancuso, Salvatrice, Vincenzo Accurso, Marco Santoro, Simona Raso, Angelo Davide Contrino, Alessandro Perez, Florinda Di Piazza, Ada Maria Florena, Antonio Russo i Sergio Siragusa. "The Essential Thrombocythemia, Thrombotic Risk Stratification, and Cardiovascular Risk Factors". Advances in Hematology 2020 (27.03.2020): 1–5. http://dx.doi.org/10.1155/2020/9124821.
Pełny tekst źródłaYamamoto, J., T. Taka, K. Yamada, Y. Ijiri, M. Murakami, Y. Hirata, A. Naemura i in. "Tomatoes have natural anti-thrombotic effects". British Journal of Nutrition 90, nr 6 (grudzień 2003): 1031–38. http://dx.doi.org/10.1079/bjn2003988.
Pełny tekst źródłaNavarro, Luana Magalhães, Damila Cristina Trufelli, Debora Rodrigues Bonito, Auro Del Giglio i Patricia Weinschenker Bollmann. "Application of prognostic score IPSET-thrombosis in patients with essential thrombocythemia of a Brazilian public service". Revista da Associação Médica Brasileira 62, nr 7 (październik 2016): 647–51. http://dx.doi.org/10.1590/1806-9282.62.07.647.
Pełny tekst źródłaChang, Simon, Christian Fynbo Christiansen, Anders Bojesen, Svend Juul, Anna-Marie B. Münster i Claus H. Gravholt. "Klinefelter syndrome and testosterone treatment: a national cohort study on thrombosis risk". Endocrine Connections 9, nr 1 (styczeń 2020): 34–43. http://dx.doi.org/10.1530/ec-19-0433.
Pełny tekst źródłaHenni, Samir, Pierre Ramondou, Guillaume Duval, Jean Picquet, Georges Leftheriotis i Pierre Abraham. "The risk of lower-limb superficial vein thrombosis relative to lower-limb venous thrombotic events is not increased in winter months". Phlebology: The Journal of Venous Disease 35, nr 7 (10.01.2020): 533–37. http://dx.doi.org/10.1177/0268355519896729.
Pełny tekst źródłaLim, Sunghee, Ji Yoon Lee, Seok Jin Kim i Won Seog Kim. "The International Prognostic Index Is a Better Predictor of Thrombotic Complications Than the Khorana Score for Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: Results of a Single Center Prospective Cohort Study". Blood 120, nr 21 (16.11.2012): 5095. http://dx.doi.org/10.1182/blood.v120.21.5095.5095.
Pełny tekst źródłaMiller, Mariel, Kamil K. Khanipov, Christopher Zahner i George K. Golovko. "Increased Risk of Thrombosis in Patients with Polycystic Ovarian Syndrome". Blood 142, Supplement 1 (28.11.2023): 5544. http://dx.doi.org/10.1182/blood-2023-190997.
Pełny tekst źródłaKreidy, Raghid. "Pathophysiology of Post-Thrombotic Syndrome: The Effect of Recurrent Venous Thrombosis and Inherited Thrombophilia". ISRN Vascular Medicine 2011 (9.11.2011): 1–4. http://dx.doi.org/10.5402/2011/513503.
Pełny tekst źródłaPark, D. J., S. E. Choi, H. Xu, J. H. Kang i S. S. Lee. "AB0442 RISK FACTORS ASSOCIATED WITH THROMBOTIC EVENTS IN KOREAN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS". Annals of the Rheumatic Diseases 79, Suppl 1 (czerwiec 2020): 1519.3–1520. http://dx.doi.org/10.1136/annrheumdis-2020-eular.1674.
Pełny tekst źródłaSiddiqui, Nadeem A., Ziad Sophie, Farhan Zafar, Delvene Soares i Iram Naz. "Predictors for the development of post-thrombotic syndrome in patients with primary lower limb deep venous thrombosis: A case–control study". Vascular 25, nr 1 (10.07.2016): 10–18. http://dx.doi.org/10.1177/1708538116636250.
Pełny tekst źródłaVassalli, Laura Coutinho, Emilia Carolina Malafaia, Maria L. Chauffaille i Daniella Kerbauy. "Leukocytosis Can Predict Thrombotic Events in Myelofibrosis". Blood 126, nr 23 (3.12.2015): 5191. http://dx.doi.org/10.1182/blood.v126.23.5191.5191.
Pełny tekst źródłaSiscovick, David, Frits Rosendaal i Alexander Reiner. "Hemostatic Risk Factors and Arterial Thrombotic Disease". Thrombosis and Haemostasis 85, nr 04 (2001): 584–95. http://dx.doi.org/10.1055/s-0037-1615638.
Pełny tekst źródłaDho-Nagy, Eszter-Anna, Attila Brassai, Patrick Lechsner, Corina Ureche i Erika-Gyöngyi Bán. "COVID-19 and Antipsychotic Therapy: Unraveling the Thrombosis Risk". International Journal of Molecular Sciences 25, nr 2 (9.01.2024): 818. http://dx.doi.org/10.3390/ijms25020818.
Pełny tekst źródłaPuetz, John, Ginger Darling, Petr Brabec, Jan Blatny i Prasad Mathew. "The Risk of Thrombotic Events in Neonates Treated with Recombinant Factor VIIa." Blood 110, nr 11 (16.11.2007): 3193. http://dx.doi.org/10.1182/blood.v110.11.3193.3193.
Pełny tekst źródłaKhidirova, L. D., N. P. Ilyinykh i P. G. Madonov. "Thrombosis on background of COVID-19 in middle-aged people". Medical alphabet, nr 19 (16.10.2022): 38–43. http://dx.doi.org/10.33667/2078-5631-2022-19-38-43.
Pełny tekst źródłaRoach, Rachel E. J., Willem M. Lijfering, Astrid van Hylckama Vlieg, Frans M. Helmerhorst, Frits R. Rosendaal i Suzanne C. Cannegieter. "The risk of venous thrombosis in individuals with a history of superficial vein thrombosis and acquired venous thrombotic risk factors". Blood 122, nr 26 (19.12.2013): 4264–69. http://dx.doi.org/10.1182/blood-2013-07-518159.
Pełny tekst źródłaHobbs, Gabriela Soriano, Minal Patel, Young Rock Chung, Omar Abdel-Wahab, Gerald A. Soff i Raajit K. Rampal. "Identification Of Markers Of Thrombotic Risk and Response To Cytoreductive Intervention In Philadelphia-Chromosome Negative Myeloproliferative Neoplams". Blood 122, nr 21 (15.11.2013): 3627. http://dx.doi.org/10.1182/blood.v122.21.3627.3627.
Pełny tekst źródłaRadaelli, Franca, Stefania Bramanti, Mariangela Colombi, Alessandra Iurlo i Alberto Zanella. "Essential Thrombocythemia: Analysis of Risk Factors for Thrombotic Events in a Series of 306 Patients." Blood 106, nr 11 (16.11.2005): 4937. http://dx.doi.org/10.1182/blood.v106.11.4937.4937.
Pełny tekst źródłaLim, Wendy. "Prevention of thrombosis in antiphospholipid syndrome". Hematology 2016, nr 1 (2.12.2016): 707–13. http://dx.doi.org/10.1182/asheducation-2016.1.707.
Pełny tekst źródłaBertina, Rogier. "Genetic Approach to Thrombophilia". Thrombosis and Haemostasis 86, nr 07 (2001): 92–103. http://dx.doi.org/10.1055/s-0037-1616205.
Pełny tekst źródłaWang, Xuekun, Yansong Tu, Mei Cao, Xiaoyan Jiang, Yazhi Yang, Xiaoyan Zhang, Hurong Lai, Huaijun Tu i Jian Li. "The Predictive Value of Neutrophil-Lymphocyte Ratio in Patients with Polycythemia Vera at the Time of Initial Diagnosis for Thrombotic Events". BioMed Research International 2022 (8.08.2022): 1–8. http://dx.doi.org/10.1155/2022/9343951.
Pełny tekst źródłaHeda, Pooja Prakash, i Ali Jafer Nejim Al-Hilly. "Thrombotic Events in Covid-19: Incidence and their Association with Lab Parameters, Vaccination Status and Mortality". Journal of the Bahrain Medical Society 34, nr 4 (2022): 1–10. http://dx.doi.org/10.26715/jbms.34_4_1.
Pełny tekst źródłaChoudry, Qamar Un-Nisa, Raheel Iftikhar, Manzur Qadir, Tariq Mehmood Satti, Ghassan Omair i Syed Kamran Mehmood. "HIGH ALTITUDE AND VENOUS THROMBOSIS: FREQUENCY AND RISK FACTORS". PAFMJ 71, nr 1 (24.02.2021): 107–11. http://dx.doi.org/10.51253/pafmj.v71i1.3173.
Pełny tekst źródłaCohen, Kenneth Roy, David Anderson, Sheng Ren i David J. Cook. "Contribution of the elevated thrombosis risk of males to the excess male mortality observed in COVID-19: an observational study". BMJ Open 12, nr 2 (luty 2022): e051624. http://dx.doi.org/10.1136/bmjopen-2021-051624.
Pełny tekst źródłaMirrakhimov, Aibek E., Alaa M. Ali, Aram Barbaryan, Suartcha Prueksaritanond i Nasir Hussain. "Primary Nephrotic Syndrome in Adults as a Risk Factor for Pulmonary Embolism: An Up-to-Date Review of the Literature". International Journal of Nephrology 2014 (2014): 1–9. http://dx.doi.org/10.1155/2014/916760.
Pełny tekst źródłaPalacios-Acedo, Ana-Luisa, Mélanie Langiu, Lydie Crescence, Diane Mège, Christophe Dubois i Laurence Panicot-Dubois. "Platelet and Cancer-Cell Interactions Modulate Cancer-Associated Thrombosis Risk in Different Cancer Types". Cancers 14, nr 3 (30.01.2022): 730. http://dx.doi.org/10.3390/cancers14030730.
Pełny tekst źródłaCedrone, Michele, Barbara Anaclerico, Francesca Paoloni, Roberto Latagliata, Marco Montanaro, Francesca Spirito, Sabrina Leonetti Crescenzi i in. "Application of the International Prognostic Score of Thrombosis for Essential Thrombocytemia(ET) (IPSET-Thrombosis) in a Cohort of ET Patients: Experience from Gruppo Laziale for Myeloproliferative Ph Negative Neoplasms". Blood 126, nr 23 (3.12.2015): 2821. http://dx.doi.org/10.1182/blood.v126.23.2821.2821.
Pełny tekst źródłaKharlamova, E. N., T. M. Reshetnyak i G. M. Tarasova. "Thrombosis risk factors in ANCA-associated vasculitis". Modern Rheumatology Journal 17, nr 2 (22.04.2023): 93–99. http://dx.doi.org/10.14412/1996-7012-2023-2-93-99.
Pełny tekst źródłaSeck, Moussa, Elimane Seydi Bousso, Sokhna Aissatou Touré, Abibatou Sall, Maryama Ndao, Sérigne Mourtalla Guèye, Blaise Félix Faye i in. "Thrombotic Events and Risk Factors for Thrombosis in Polycythemia in Senegal, West Africa". Journal of Clinical Haematology 4, nr 1 (5.06.2023): 1–8. http://dx.doi.org/10.33696/haematology.4.052.
Pełny tekst źródłaKahn, Susan R. "The post-thrombotic syndrome". Hematology 2016, nr 1 (2.12.2016): 413–18. http://dx.doi.org/10.1182/asheducation-2016.1.413.
Pełny tekst źródłaRuffatti, A., T. Del Ross, M. Ciprian, M. Nuzzo, M. Rampudda, M. T. Bertero, R. Bergia i in. "Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicentre, retrospective follow-up study". Annals of the Rheumatic Diseases 68, nr 3 (23.09.2008): 397–99. http://dx.doi.org/10.1136/ard.2008.096669.
Pełny tekst źródłaChaireti, Roza, i Hareth Nahi. "Risk Factors and Risk Stratification of Thromboembolic Risk in Patients with Multiple Myeloma". Hemato 3, nr 3 (29.08.2022): 518–26. http://dx.doi.org/10.3390/hemato3030036.
Pełny tekst źródłaMancini, Mariangela, Gianmarco Randazzo, Gregory Piazza i Fabrizio Dal Moro. "Arterial Thrombotic Complications in COVID-19: A Case of Renal Infarction". Biomedicines 10, nr 10 (21.09.2022): 2354. http://dx.doi.org/10.3390/biomedicines10102354.
Pełny tekst źródłaZhang, Xueya, Xuerong Cai i Jingxin Pan. "Correlation Between PAI-1 Gene 4G/5G Polymorphism and the Risk of Thrombosis in Ph Chromosome-Negative Myeloproliferative Neoplasms". Clinical and Applied Thrombosis/Hemostasis 26 (1.01.2020): 107602962093520. http://dx.doi.org/10.1177/1076029620935207.
Pełny tekst źródłaBuxhofer-Ausch, Veronika, Heinz Gisslinger, Juergen Thiele, Bettina Gisslinger, Hans-Michael Kvasnicka, Leonhard Müllauer, Sophie Frantal i in. "Risk Factors for Thrombosis in WHO-Defined Early/Prefibrotic Myelofibrosis: An International Study of 264 Patients",. Blood 118, nr 21 (18.11.2011): 3846. http://dx.doi.org/10.1182/blood.v118.21.3846.3846.
Pełny tekst źródłaGrover, Steven P., Yohei M. Hisada, Raj S. Kasthuri, Brandi N. Reeves i Nigel Mackman. "Cancer Therapy–Associated Thrombosis". Arteriosclerosis, Thrombosis, and Vascular Biology 41, nr 4 (kwiecień 2021): 1291–305. http://dx.doi.org/10.1161/atvbaha.120.314378.
Pełny tekst źródłaSrisuwananukorn, Andrew, Rasha Raslan, Xu Zhang, Binal N. Shah, Jin Han, Michel Gowhari, Robert E. Molokie, Victor R. Gordeuk i Santosh L. Saraf. "Clinical, laboratory, and genetic risk factors for thrombosis in sickle cell disease". Blood Advances 4, nr 9 (8.05.2020): 1978–86. http://dx.doi.org/10.1182/bloodadvances.2019001384.
Pełny tekst źródłaVera, Rodrigo Hernández, Gemma Vilahur i Lina Badimon. "Obesity with insulin resistance increase thrombosis in wild-type and bone marrow-transplanted Zucker fatty rats". Thrombosis and Haemostasis 109, nr 02 (2013): 319–27. http://dx.doi.org/10.1160/th12-09-0696.
Pełny tekst źródłaPósfai, Éva, Imelda Marton, Attila Nemes i Zita Borbényi. "Thrombotic events and importance of IPSET thrombosis risk evaluation score in essential thrombocythaemia". Orvosi Hetilap 156, nr 14 (kwiecień 2015): 558–63. http://dx.doi.org/10.1556/oh.2015.30117.
Pełny tekst źródłaMishcheniuk, O. Y., O. M. Kostiukevych, L. K. Benkovska i A. N. Kravchenko. "THE CONTRIBUTION OF CARRIER THE ALLELIC VARIANT G1691A OF THE GENE V OF COAGULATION FACTOR TO THE DEVELOPMENT OF THROMBOTIC COMPLICATIONS DEPENDING ON THE PRESENCE OF CARDIOVASCULAR RISK FACTORS IN INDIVIDUALS WITH SECONDARY LEUKOCYTOSIS, THROMBOCYTOSIS A". Клінічна та профілактична медицина 4, nr 9-10 (17.10.2019): 61–67. http://dx.doi.org/10.31612/2616-4868.3(9).2019.08.
Pełny tekst źródłaAlabyad, Darwish, Srikant Rangaraju, Michael Liu, Rajeel Imran, Christine L. Kempton, Milad Sharifpour, Sara C. Auld i in. "Validation of an admission coagulation panel for risk stratification of COVID-19 patients". PLOS ONE 16, nr 3 (19.03.2021): e0248230. http://dx.doi.org/10.1371/journal.pone.0248230.
Pełny tekst źródłaCattaneo, Marco. "Hyperhomocysteinemia, Atherosclerosis and Thrombosis". Thrombosis and Haemostasis 81, nr 02 (1999): 165–76. http://dx.doi.org/10.1055/s-0037-1614438.
Pełny tekst źródłaFranchini, Massimo. "Thrombotic complications in patients with hereditary bleeding disorders". Thrombosis and Haemostasis 92, nr 08 (2004): 298–304. http://dx.doi.org/10.1160/th04-03-0148.
Pełny tekst źródłaDeRoo, Scott, K. Barry Deatrick i Peter Henke. "The vessel wall: A forgotten player in post thrombotic syndrome". Thrombosis and Haemostasis 104, nr 10 (2010): 681–92. http://dx.doi.org/10.1160/th10-03-0183.
Pełny tekst źródłaCortelazzo, S., P. Viero, G. Finazzi, A. D'Emilio, F. Rodeghiero i T. Barbui. "Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia." Journal of Clinical Oncology 8, nr 3 (marzec 1990): 556–62. http://dx.doi.org/10.1200/jco.1990.8.3.556.
Pełny tekst źródłaZapletal, Ondrej, Jan Blatny i Eva Janousova. "Inherited Pro-Thrombotic Risk Factors in Children of South Moravia Region, Czech Republic". Blood 120, nr 21 (16.11.2012): 5136. http://dx.doi.org/10.1182/blood.v120.21.5136.5136.
Pełny tekst źródłaLugacheva, Yu G., I. V. Kulagina, I. A. Kovalev, Ye V. Krivoschekov, O. S. Yanulevich i T. E. Suslova. "Risk factors of thrombotic complications in patients with single functional ventricle". Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 64, nr 2 (15.05.2019): 68–74. http://dx.doi.org/10.21508/1027-4065-2019-64-2-68-74.
Pełny tekst źródłaCapecchi, Marco, Alessandro Ciavarella, Andrea Artoni, Maria Abbattista i Ida Martinelli. "Thrombotic Complications in Patients with Immune-Mediated Hemolysis". Journal of Clinical Medicine 10, nr 8 (18.04.2021): 1764. http://dx.doi.org/10.3390/jcm10081764.
Pełny tekst źródłaLINDQVIST, PELLE, BJÖRN DAHLBÄCK i KAREL MARŜÁL. "Thrombotic Risk During Pregnancy". Obstetrics & Gynecology 94, nr 4 (październik 1999): 595–99. http://dx.doi.org/10.1097/00006250-199910000-00021.
Pełny tekst źródła